Literature DB >> 13680364

Refinement of the Silver syndrome locus on chromosome 11q12-q14 in four families and exclusion of eight candidate genes.

Christian Windpassinger1, Klaus Wagner, Erwin Petek, Renate Fischer, Michaela Auer-Grumbach.   

Abstract

Silver syndrome is a rare variant of autosomal dominant complicated hereditary spastic paraparesis (HSP), in which spasticity of the lower limbs is accompanied by amyotrophy of the hands and occasionally also the lower limbs. The disease locus has been mapped to chromosome 11q12-q14. We report four Austrian families presenting with the typical clinical features of Silver syndrome. Sixteen individuals were affected upon clinical and/or electrophysiological examination. Ten persons showed mild to severe spasticity of the lower limbs. Wasting of the small hand muscles was present in nine affected family members of whom three had also gait disturbance. Three further individuals were asymptomatic. Electrophysiological studies showed normal or slightly to moderately slowed motor nerve conduction velocities, reduced amplitudes and occasionally chronodispersion of compound motor action potentials. In one patient, conduction block was observed. Sensory nerve action potentials were usually normal. Molecular genetic studies demonstrate linkage to chromosome 11q12-q14. Haplotype analysis in affected individuals indicates a common ancestor in the four families. By recombination analysis in affected individuals the Silver syndrome candidate gene interval can be reduced from 13 to 5.9 cM and can now be placed between the markers D11S1765 and D11S987. By sequence analysis of affected individuals eight functional and positional candidate genes could be excluded. Our study confirms the existence of the Silver syndrome locus on chromosome 11q12-q14 and provides the first report of nerve conduction velocity studies in Silver syndrome, which demonstrate the presence of a peripheral predominantly motor neuropathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680364     DOI: 10.1007/s00439-003-1021-6

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

1.  Conduction block in clinical practice.

Authors:  D R Cornblath; A J Sumner; J Daube; R W Gilliat; W F Brown; G J Parry; J W Albers; R G Miller; J Petajan
Journal:  Muscle Nerve       Date:  1991-09       Impact factor: 3.217

2.  Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia.

Authors:  J Hazan; N Fonknechten; D Mavel; C Paternotte; D Samson; F Artiguenave; C S Davoine; C Cruaud; A Dürr; P Wincker; P Brottier; L Cattolico; V Barbe; J M Burgunder; J F Prud'homme; A Brice; B Fontaine; B Heilig; J Weissenbach
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

3.  Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13.

Authors:  J Magré; M Delépine; E Khallouf; T Gedde-Dahl; L Van Maldergem; E Sobel; J Papp; M Meier; A Mégarbané; A Bachy; A Verloes; F H d'Abronzo; E Seemanova; R Assan; N Baudic; C Bourut; P Czernichow; F Huet; F Grigorescu; M de Kerdanet; D Lacombe; P Labrune; M Lanza; H Loret; F Matsuda; J Navarro; A Nivelon-Chevalier; M Polak; J J Robert; P Tric; N Tubiana-Rufi; C Vigouroux; J Weissenbach; S Savasta; J A Maassen; O Trygstad; P Bogalho; P Freitas; J L Medina; F Bonnicci; B I Joffe; G Loyson; V R Panz; F J Raal; S O'Rahilly; T Stephenson; C R Kahn; M Lathrop; J Capeau
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

4.  Distal amyotrophy of predominantly the upper limbs with pyramidal features in a large kinship.

Authors:  E M van Gent; R A Hoogland; F G Jennekens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-03       Impact factor: 10.154

5.  Amyotrophy of the hands and pyramidal features of predominantly the legs segregating within one large family.

Authors:  M de Visser; B W Ongerboer de Visser; M Verjaal
Journal:  J Neurol Sci       Date:  1988-12       Impact factor: 3.181

6.  Mapping of a distal form of spinal muscular atrophy with upper limb predominance to chromosome 7p.

Authors:  K Christodoulou; T Kyriakides; A H Hristova; D M Georgiou; L Kalaydjieva; B Yshpekova; T Ivanova; J L Weber; L T Middleton
Journal:  Hum Mol Genet       Date:  1995-09       Impact factor: 6.150

7.  SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia.

Authors:  Heema Patel; Harold Cross; Christos Proukakis; Ruth Hershberger; Peer Bork; Francesca D Ciccarelli; Michael A Patton; Victor A McKusick; Andrew H Crosby
Journal:  Nat Genet       Date:  2002-07-22       Impact factor: 38.330

8.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Hereditary motor peripheral neuropathy predominantly affecting the arms.

Authors:  C M Lander; M J Eadie; J H Tyrer
Journal:  J Neurol Sci       Date:  1976-07       Impact factor: 3.181

10.  Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease.

Authors:  G Casari; M De Fusco; S Ciarmatori; M Zeviani; M Mora; P Fernandez; G De Michele; A Filla; S Cocozza; R Marconi; A Dürr; B Fontaine; A Ballabio
Journal:  Cell       Date:  1998-06-12       Impact factor: 41.582

View more
  9 in total

1.  ALS and MMN mimics in patients with BSCL2 mutations: the expanding clinical spectrum of SPG17 hereditary spastic paraplegia.

Authors:  Thomas Musacchio; Ann-Kathrin Zaum; Nurcan Üçeyler; Claudia Sommer; Nora Pfeifroth; Karlheinz Reiners; Erdmute Kunstmann; Jens Volkmann; Simone Rost; Stephan Klebe
Journal:  J Neurol       Date:  2016-10-13       Impact factor: 4.849

2.  Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease.

Authors:  Chi-Hui Tang; Je-Wook Lee; Michael G Galvez; Liliane Robillard; Sara E Mole; Harold A Chapman
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

3.  The first Italian family with evidence of pyramidal impairment as phenotypic manifestation of Silver syndrome BSCL2 gene mutation.

Authors:  Gianfranco Cafforio; Rosanna Calabrese; Nicola Morelli; Michelangelo Mancuso; Selina Piazza; Andrea Martinuzzi; Maria Teresa Bassi; Francesco Crippa; Gabriele Siciliano
Journal:  Neurol Sci       Date:  2008-07-09       Impact factor: 3.307

4.  Hereditary spastic paraplegia and amyotrophy associated with a novel locus on chromosome 19.

Authors:  K G Meilleur; M Traoré; M Sangaré; A Britton; G Landouré; S Coulibaly; B Niaré; F Mochel; A La Pean; I Rafferty; C Watts; D Shriner; M T Littleton-Kearney; C Blackstone; A Singleton; K H Fischbeck
Journal:  Neurogenetics       Date:  2009-12-29       Impact factor: 2.660

Review 5.  Exploring Seipin: From Biochemistry to Bioinformatics Predictions.

Authors:  Aquiles Sales Craveiro Sarmento; Lázaro Batista de Azevedo Medeiros; Lucymara Fassarella Agnez-Lima; Josivan Gomes Lima; Julliane Tamara Araújo de Melo Campos
Journal:  Int J Cell Biol       Date:  2018-09-19

6.  Promethin Is a Conserved Seipin Partner Protein.

Authors:  Inês G Castro; Michal Eisenberg-Bord; Elisa Persiani; Justin J Rochford; Maya Schuldiner; Maria Bohnert
Journal:  Cells       Date:  2019-03-21       Impact factor: 6.600

7.  Usefulness of comprehensive targeted multigene panel sequencing for neuromuscular disorders in Korean patients.

Authors:  Jihye Park; Hyun Mi Oh; Hye Jung Park; Ah-Ra Cho; Dong-Woo Lee; Ja-Hyun Jang; Dae-Hyun Jang
Journal:  Mol Genet Genomic Med       Date:  2019-09-01       Impact factor: 2.183

Review 8.  Towards a mechanistic understanding of lipodystrophy and seipin functions.

Authors:  Kenneth Wee; Wulin Yang; Shigeki Sugii; Weiping Han
Journal:  Biosci Rep       Date:  2014-10-02       Impact factor: 3.840

9.  Screening for SH3TC2, PMP2, and BSCL2 Variants in a Cohort of Chinese Patients with Charcot-Marie-Tooth.

Authors:  Xin Zhao; Ming-Ming Jiang; Yi-Zhou Yan; Lei Liu; Yong-Zhi Xie; Xiao-Bo Li; Zheng-Mao Hu; Xiao-Hong Zi; Kun Xia; Bei-Sha Tang; Ru-Xu Zhang
Journal:  Chin Med J (Engl)       Date:  2018-01-20       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.